Canaccord discloses 4.1832% stake after selling 5,905 Advanced Medical Solutions shares

Verifying
  • Canaccord Genuity Wealth disclosed its Advanced Medical Solutions shareholding under Rule 8.3.
  • 9,236,640 shares represented 4.1832%; 5,905 shares were sold at 281p each.
  • The disclosure was dated September 11, 2026, following dealings on September 10.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.